Efficacy of Clinically Used PARP Inhibitors in a Murine Model of Acute Lung Injury
Article in Cells (November 2022)
The most recent citing publications are shown below. View all 52 publications that cite this research output on Dimensions.
Poly(ADP-Ribose) Polymerase Inhibition in Acute Lung Injury. A Reemerging Concept
Article in American Journal of Respiratory Cell and Molecular Biology (November 2020)
Pharmacological inhibition of poly (ADP-ribose) polymerase by olaparib, prevents acute lung injury associated cognitive deficits potentially through suppression of inflammatory response
Article in European Journal of Pharmacology (March 2020)